Cost‐effectiveness of investing in earlier access to diabetic foot services: A multi‐centre pre‐post study
Diabetic Medicine · 26.05.2026
DOI: 10.1111/dme.70373 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 26.05.2026. Verfasst von Son Nghiem und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Applied Health Economics, Griffith University, Brisbane, Queensland, Australia. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council - Investigator Grant Fellowship (#2034266).
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Aims
We evaluated the cost‐effectiveness of implementing a novel funding model to incentivise earlier access of patients with diabetes‐related foot disease (DFD) to diabetic foot services (DFS).
Methods
In this multi‐centre pre‐post study, we compared the cost, quality‐adjusted life year (QALY) and clinical outcomes of patients with diabetes‐related foot disease who had usual access to ambulatory DFS (controls) to patients who accessed the new DFS (intervention) across 15 regions in Queensland, Australia. A generalised linear model was used to estimate the difference in controls and intervention group outcomes, and a Bayesian Markov model estimated transition probabilities between seven health states over a 5‐year time horizon from an Australian health service perspective.
Results
Overall, 1687 patients were included (830 control, 857 intervention). Compared to controls, the intervention group had a lower projected probability of hospitalisation, particularly after 20 months. The intervention also had reduced costs (−$8429 [95% confidence intervals: −$8461, −$8397]) and increased QALYs (0.06 [0.05, 0.07]) compared to controls. On average, $AU1 invested in the intervention generated a return of $AU7.86 [$7.63, $8.09].
Conclusions
We found investing in earlier access to DFS to be cost‐effective and generated considerably improved patient outcomes, cost savings, and return on investment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Applied Health Economics, Griffith University, Brisbane, Queensland, Australia.
- Lac Hong University, Bien Hoa, Dong Nai, Vietnam.
- Allied Health Research Collaborative, The Prince Charles Hospital, Brisbane, Queensland, Australia.
- Australian Centre for Health Services Innovation, School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
- Cairns Diabetes Centre, Cairns and Hinterland Hospital and Health Service, and Metro North Hospital and Health Service, Herston, Queensland, Australia.
- Chronic Disease Brisbane South, Community and Oral Health, Inala Community Health Centre, Metro South Health, Eight Mile Plains, Queensland, Australia.
ORCID-Profile: Peter A Lazzarini, Lauren T Ward
Förderung
- National Health and Medical Research Council - Investigator Grant Fellowship (#2034266)
Zitieren
APA
Nghiem, S., Lazzarini, P. A., Ward, L. T., Jensen, S., Charles, D., Mann, R., Sagoo, M., Finch, J., Gavaghan, B., McBride, L. J., & Byrnes, J. (2026). Cost‐effectiveness of investing in earlier access to diabetic foot services: A multi‐centre pre‐post study. Diabetic Medicine. https://doi.org/10.1111/dme.70373
Vancouver
Nghiem S, Lazzarini PA, Ward LT, Jensen S, Charles D, Mann R, et al. Cost‐effectiveness of investing in earlier access to diabetic foot services: A multi‐centre pre‐post study. Diabetic Medicine. 2026. doi:10.1111/dme.70373
BibTeX
@article{Nghiem2026,
author = {Nghiem, Son and Lazzarini, Peter A and Ward, Lauren T and Jensen, Sarah and Charles, Danielle and Mann, Rebecca and Sagoo, Manjeet and Finch, Jennifer and Gavaghan, Belinda and McBride, Liza-Jane and Byrnes, Joshua},
title = {Cost‐effectiveness of investing in earlier access to diabetic foot services: A multi‐centre pre‐post study},
journal = {Diabetic Medicine},
year = {2026},
doi = {10.1111/dme.70373}
}
EUVIMED